Predictimmune
Latest round
- Series B
Last raised
- Jul 2019
Total raised
- $18M
Investors
- 5
About Predictimmune
Predictimmune Limited, founded in 2017, is headquartered in Cambridge, UK. The company specializes in diagnostics aimed at predicting disease progression and treatment responses for patients with complex immunological conditions.Predictimmune focuses on providing advanced diagnostic solutions aimed at enhancing patient outcomes in autoimmunity and transplant medicine. Their core product offerings include innovative tests designed to predict disease progression and treatment responses in patients suffering from complex immunological conditions. These tests leverage proprietary algorithms and biomarkers to offer clinicians actionable insights, facilitating personalized treatment plans that target specific patient needs.40. The company's revenue generation is primarily derived from the sale of their diagnostic products through a B2B model, where healthcare providers and institutions engage with the company to acquire testing services. The company is focused on enhancing its test offerings, with plans for release in the coming years, while targeting expansion in North America and Europe by 2024. This strategy aims to address the growing demand for advanced diagnostic solutions in managing autoimmune disorders and organ transplant monitoring.
Who invested in Predictimmune
5 investors across 2 rounds
See all investors in Predictimmune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Predictimmune
Who invested in Predictimmune?
Predictimmune has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Predictimmune raised?
Predictimmune has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Predictimmune last raise money?
Predictimmune's most recent round on record is a Series B, in Jul 2019.
What does Predictimmune do?
Predictimmune Limited, founded in 2017, is headquartered in Cambridge, UK.
Where is Predictimmune headquartered?
Predictimmune is headquartered in Cambridge, UK.
Which VCs invest in companies like Predictimmune?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back healthcare it companies at Predictimmune's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Predictimmune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.